Carregant...

MicroRNA 9-3p Targets β(1) Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition

MEK1/2 inhibitors such as AZD6244 are in clinical trials for the treatment of multiple cancers, including breast cancer. Targeted kinase inhibition can induce compensatory kinome changes, rendering single therapeutic agents ineffective. To identify target proteins to be used in a combinatorial appro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zawistowski, Jon S., Nakamura, Kazuhiro, Parker, Joel S., Granger, Deborah A., Golitz, Brian T., Johnson, Gary L.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3648081/
https://ncbi.nlm.nih.gov/pubmed/23530058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/MCB.00269-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!